What are the differences between Skyla (levonorgestrel) and Kyleena (levonorgestrel) intrauterine devices (IUDs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differences Between Skyla and Kyleena IUDs

Kyleena contains more levonorgestrel (19.5 mg) than Skyla (13.5 mg) and is approved for 5 years of use compared to Skyla's 3 years, making Kyleena the superior choice for patients seeking longer-term contraception with slightly higher hormone levels.

Key Differences

Feature Skyla Kyleena
Hormone content 13.5 mg levonorgestrel 19.5 mg levonorgestrel
Duration of use 3 years 5 years
Size Smaller T-frame Smaller T-frame (similar to Skyla)
Efficacy >99% >99%

Mechanism and Efficacy

Both Skyla and Kyleena are hormonal intrauterine devices (IUDs) that:

  • Release levonorgestrel directly into the uterine cavity
  • Cause endometrial suppression
  • Thicken cervical mucus
  • Have typical and perfect use failure rates of less than 1% 1
  • Are considered long-acting reversible contraception (LARC) methods

Clinical Considerations for Selection

When to Choose Kyleena

  • For patients needing longer-term contraception (5 years vs. 3 years)
  • When slightly higher hormone levels are desired
  • For patients who may benefit from more significant reduction in menstrual bleeding (due to higher hormone content)

When to Choose Skyla

  • For patients who prefer or need lower hormone exposure
  • For nulliparous adolescents or women with smaller uterine cavities
  • When shorter duration of contraception is desired

Side Effects and Bleeding Patterns

Both IUDs may cause:

  • Unscheduled spotting or light bleeding, especially during the first 3-6 months 2
  • Potential dyspareunia that may require evaluation
  • Potential for hormonal side effects (though minimal compared to systemic hormonal methods)

Kyleena, with its higher hormone content, may provide better control of menstrual bleeding compared to Skyla, though both cause less menstrual bleeding than non-hormonal IUDs 2.

Insertion and Removal

Both devices:

  • Require insertion by a trained clinician
  • Have similar insertion procedures
  • Can be removed at any time with rapid return to fertility
  • Have risk of pelvic infection highest in the first 20 days after insertion 2

Special Considerations

Contraindications for Both

  • Current purulent cervicitis
  • Active gonorrhea or chlamydia infection
  • Current pelvic inflammatory disease (PID)
  • Pregnancy
  • Uterine anomalies that distort the cavity 2

Important Clinical Pearls

  • Both IUDs can be used in nulliparous women
  • Neither IUD causes tubal infertility
  • Fertility returns rapidly after removal of either device
  • Both provide excellent contraception with minimal systemic effects
  • The risk of ectopic pregnancy is reduced compared to no contraception, though any pregnancy that does occur has a higher chance of being ectopic 3

Conclusion

When choosing between Skyla and Kyleena, the primary considerations should be the desired duration of contraception and the appropriate hormone level for the individual patient. Kyleena offers a longer duration of use with slightly higher hormone levels, while Skyla provides a shorter duration with lower hormone exposure.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Dyspareunia in IUD Users

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.